244 related articles for article (PubMed ID: 11185634)
1. Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers.
Stangier J; Su CA; Schöndorfer G; Roth W
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1355-64. PubMed ID: 11185634
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients.
Stangier J; Su CA; Roth W
J Int Med Res; 2000; 28(4):149-67. PubMed ID: 11014323
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers.
Stangier J; Su CA; Brickl R; Franke H
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1365-72. PubMed ID: 11185635
[TBL] [Abstract][Full Text] [Related]
4. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers.
Stangier J; Schmid J; Türck D; Switek H; Verhagen A; Peeters PA; van Marle SP; Tamminga WJ; Sollie FA; Jonkman JH
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1312-22. PubMed ID: 11185629
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers.
Stangier J; Su CA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1347-54. PubMed ID: 11185633
[TBL] [Abstract][Full Text] [Related]
6. Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects.
Young CL; Dias VC; Stangier J
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1323-30. PubMed ID: 11185630
[TBL] [Abstract][Full Text] [Related]
7. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.
Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
[TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetics, pharmacodynamics and tolerability of donepezil hydrochloride in hepatically impaired patients.
Reyes JF; Vargas R; Kumar D; Cullen EI; Perdomo CA; Pratt RD
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):9-17. PubMed ID: 15496218
[TBL] [Abstract][Full Text] [Related]
10. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
Smith DH; Matzek KM; Kempthorne-Rawson J
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and safety of galantamine in subjects with hepatic impairment and healthy volunteers.
Zhao Q; Iyer GR; Verhaeghe T; Truyen L
J Clin Pharmacol; 2002 Apr; 42(4):428-36. PubMed ID: 11936568
[TBL] [Abstract][Full Text] [Related]
12. An open-label, single-dose, parallel-group study of the effects of chronic hepatic impairment on the safety and pharmacokinetics of desvenlafaxine.
Baird-Bellaire S; Behrle JA; Parker VD; Patat A; Paul J; Nichols AI
Clin Ther; 2013 Jun; 35(6):782-94. PubMed ID: 23623756
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment.
de Zeeuw D; Remuzzi G; Kirch W
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S37-42. PubMed ID: 9331004
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers.
Stangier J; Su CA; Fraunhofer A; Tetzloff W
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1338-46. PubMed ID: 11185632
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
Chae DW; Son M; Kim Y; Son H; Jang SB; Seo JM; Nam SY; Park K
Int J Clin Pharmacol Ther; 2015 Oct; 53(10):883-9. PubMed ID: 26329347
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of telmisartan in healthy Chinese subjects after oral administration of two dosage levels.
Zhang P; Zhang Y; Chen X; Li R; Yin J; Zhong D
Arzneimittelforschung; 2006; 56(8):569-73. PubMed ID: 17009837
[TBL] [Abstract][Full Text] [Related]
17. Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension.
Wells TG; Portman R; Norman P; Haertter S; Davidai G; Fei Wang
Clin Pediatr (Phila); 2010 Oct; 49(10):938-46. PubMed ID: 20724342
[TBL] [Abstract][Full Text] [Related]
18. Analyzing rich data using different methods provided by NONMEM: pharmacokinetics of telmisartan following intravenous infusion to healthy volunteers.
Wallenstein GC; Stangier J; Ludden TM
Pharm Res; 1999 May; 16(5):772-6. PubMed ID: 10350024
[No Abstract] [Full Text] [Related]
19. Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteers.
Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1331-7. PubMed ID: 11185631
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
